Search

everythinglearnresearchcommunity

for

Search:↓

Combining low-level laser therapy with scalp microneedling and a clobetasol solution significantly improves androgenetic alopecia.

Activating β-catenin increases melanocytes and decreases Schwann cells.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

A new platinum complex was made and studied, which might help fight cancer better.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Mutations in the LSS gene cause hair loss and may affect brain development, with varying severity.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

The RHD4 gene is crucial for consistent root hair growth in Arabidopsis thaliana.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

Tcf3 and Lef1 are key in deciding skin stem cell roles.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

A CCS patient with severe complications was successfully treated using combined therapies.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A mutation in the IL2RA gene increases the risk of alopecia areata.

People with celiac disease have a higher risk of developing alopecia areata.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Gut bacteria differences could help diagnose and treat alopecia areata.